Brian Case
Chief Tech/Sci/R&D Officer presso KORU MEDICAL SYSTEMS, INC.
Patrimonio netto: 280 250 $ in data 31/03/2024
Profilo
Brian Case is currently the Chief Technology Officer at KORU Medical Systems, Inc. Prior to his current position, he served as the Vice President-Research & Development at Fresenius Kabi AG from 2006 to 2022.
Mr. Case holds a graduate degree from Rose-Hulman Institute of Technology, Inc. and an undergraduate degree from the University of Illinois.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
24/03/2024 | 118 750 ( 0.26% ) | 280 250 $ | 31/03/2024 |
Posizioni attive di Brian Case
Società | Posizione | Inizio |
---|---|---|
KORU MEDICAL SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | 18/04/2022 |
Precedenti posizioni note di Brian Case
Società | Posizione | Fine |
---|---|---|
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Chief Tech/Sci/R&D Officer | 01/05/2022 |
Formazione di Brian Case
Rose-Hulman Institute of Technology, Inc. | Graduate Degree |
University of Illinois | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
KORU MEDICAL SYSTEMS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Health Technology |
- Borsa valori
- Insiders
- Brian Case